SCHEMBL5677385

SCHEMBL5677385

NC(=O)Cc1cccc(-c2ccc(F)nc2)c1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
EPHB4 P54760 1/20 0.46
MAP4K4 O95819 1/20 0.43
SRC P12931 1/20 0.43
ICMT O60725 2/20 0.42
RORC P51449 1/20 0.41
CHEK2 O96017 1/20 0.40
WNT3A P56704 1/20 0.40
DHODH Q02127 1/20 0.40
CYP4F2 P78329 1/20 0.39
CYP4A11 Q02928 1/20 0.39
NPC1 O15118 1/20 0.39
HPGD P15428 1/20 0.39
NFKB1 P19838 1/20 0.39
STAT1 P42224 1/20 0.39
RAB9A P51151 1/20 0.39
NFKB2 Q00653 1/20 0.39
RELA Q04206 1/20 0.39
AOC3 Q16853 2/20 0.39
MAOA P21397 1/20 0.39
MAOB P27338 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15782613 0.82 ICMT (0.55) SRCICMT
SCHEMBL16675747 0.80 PRKCI (0.53)
SCHEMBL5176875 0.78 EPHX2 (0.55)
SCHEMBL5675196 0.78 TAAR1 (0.55) MAOB
SCHEMBL24721758 0.77 BCL2 (0.47) CYP4F2CYP4A11
SCHEMBL5215922 0.77 CYP11B2 (0.42) MAP4K4SRCWNT3A
SCHEMBL23374458 0.76 CA2 (0.48)
SCHEMBL254913 0.76 RORC (0.54) RORCNPC1HPGDNFKB1STAT1
SCHEMBL5178108 0.76 AKT1 (0.43) EPHB4RORCWNT3ACYP4F2CYP4A11
SCHEMBL11364655 0.76 AOC3 (0.67) AOC3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1565190-A4 ARYLCYCLOPROPYLCARBOXYLIC AMIDES AS POTASSIUM CHANNEL OPENERS BRISTOL MYERS SQUIBB CO (US) 2006-04-26 EP claimed
EP-1565190-A2 ARYLCYCLOPROPYLCARBOXYLIC AMIDES AS POTASSIUM CHANNEL OPENERS Bristol-Myers Squibb Company (US) 2005-08-24 EP claimed
WO-2004047738-A2 ARYLCYCLOPROPYLCARBOXYLIC AMIDES AS POTASSIUM CHANNEL OPENERS BRISTOL-MYERS SQUIBB COMPANY (US) 2004-06-10 WO claimed
WO-2024054811-A1 COMBINATION THERAPIES INCLUDING METAL CHANNEL ACTIVATORS BIOHAVEN THERAPEUTICS LTD. (VG) 2024-03-14 WO disclosed